feed,title,long_url,short_url
MedRxiv,Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance,https://medrxiv.org/cgi/content/short/2022.02.17.22271099v1?rss=1,https://bit.ly/3gTJE9U
MedRxiv,Autoantibodies linked to autoimmune diseases associate with COVID-19 outcomes,https://medrxiv.org/cgi/content/short/2022.02.17.22271057v1?rss=1,https://bit.ly/3H6un0s
MedRxiv,COVID-19-related Smell and Taste Impairment with Widespread Diffusion of SARS-CoV-2 Omicron Variant,https://medrxiv.org/cgi/content/short/2022.02.17.22271116v1?rss=1,https://bit.ly/3GZ6bNk
MedRxiv,"Serological responses and six-month trajectories to COVID-19 Comirnaty and Spikevax booster vaccine, September 2021 to January 2022, London, United Kingdom",https://medrxiv.org/cgi/content/short/2022.02.17.22271126v1?rss=1,https://bit.ly/355UNSG
